Skip to Main Content

Paper Details

Discovery and Pharmacological Characterization of JNJ-64619178, a Novel Small-Molecule Inhibitor of PRMT5 with Potent Antitumor Activity.
Mol Cancer Ther
39
2021
JNJ-64619178, PRMT5, advanced, arginine, breast cancer, cancer, cancer cell lines, cancers, hematological malignancies, lung cancer, lymphomas, myelodysplastic syndrome, non-Hodgkin's lymphoma, patients, primary, primary acute myelogenous leukemia, protein arginine methyltransferase 5, tumor, tumors, xenograft models
Author NameAffiliation
Vipul Bhargava
Timothy A GraubertMassachusetts General Hospital Cancer Center, Harvard Medical School
  • 1 - 2

Datasets

Release 1.2